Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
189 hedge funds and large institutions have $941M invested in Meridian Bioscience Inc in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 73 reducing their positions, and 47 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
12% less funds holding
Funds holding: 215 → 189 (-26)
13% less capital invested
Capital invested by funds: $1.08B → $941M (-$136M)
14% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 73
39% less call options, than puts
Call options by funds: $5.92M | Put options by funds: $9.64M
55% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$25.9M |
| 2 |
DM
Deerfield Management
New York
|
+$11.3M |
| 3 |
BlackRock
New York
|
+$10.2M |
| 4 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
+$9.39M |
| 5 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
+$8.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.3M |
| 2 |
EARNEST Partners
Atlanta,
Georgia
|
-$9.67M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.65M |
| 4 |
PFC
Phocas Financial Corp
Alameda,
California
|
-$3.54M |
| 5 |
Goldman Sachs
New York
|
-$3.39M |
VIVO Hedge Fund Activity: Q2 2021 in Review
189 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2021, worth a combined $941M — down 13% from $1.08B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of VIVO and 21 opened new positions — a net loss of 26 holders — while 73 trimmed existing stakes and 63 added.
The largest buyer was Royce & Associates, adding an estimated $25.9M. The largest seller was Fidelity Investments, cutting an estimated $10.3M.
- 189 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2021, down from 215 in Q1 2021.
- Funds reported $941M of Meridian Bioscience Inc stock for Q2 2021, down 13% quarter-over-quarter.
- 21 funds opened new Meridian Bioscience Inc positions in Q2 2021 and 47 closed out, a net change of -26 holders.
- The largest Meridian Bioscience Inc buyer in Q2 2021 was Royce & Associates, an estimated $25.9M added.
- The largest Meridian Bioscience Inc seller in Q2 2021 was Fidelity Investments, an estimated $10.3M sold.
Based on aggregated 13F filings for Q2 2021.